Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Surrozen, Inc. (SRZN : NSDQ)

• Company Description    Surrozen Inc. is a company pioneering targeted therapeutics which selectively activates the Wnt pathway for tissue repair and regeneration. Surrozen Inc., formerly known as Consonance-HFW Acquisition Corp., is based in SOUTH SAN FRANCISCO, Calif. Number of Employees: 41

• Price / Volume Information    Yesterday's Closing Price: $22.60 Daily Weekly Monthly 20 Day Moving Average: 96,548 shares Shares Outstanding: 8.57 (millions) Market Capitalization: $193.71 (millions) Beta: 0.58 52 Week High: $24.94 52 Week Low: $5.90 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 23.97% 24.18% 12 Week 64.36% 61.71% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 171 Oyster Point Blvd Suite 400 - South San Francisco,CA 94080 USA ph: 650-489-9000 fax: - investorinfo@surrozen.com http://www.surrozen.com

• General Corporate Information    Officers Craig Parker - President and Chief Executive Officer and Director David J. Woodhouse - Chair of the Board of Directors Charles Williams - Chief Financial Officer and Chief Operating Office Anna Berkenblit - Director Christopher Chai - Director Peer Information Surrozen, Inc. (GSAC) Surrozen, Inc. (CASI) Surrozen, Inc. (ALCD.) Surrozen, Inc. (OMNN) Surrozen, Inc. (CGPI.) Surrozen, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 86889P208 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/30/26 Share - Related Items Shares Outstanding: 8.57 Most Recent Split Date: 12.00 (0.07:1) Beta: 0.58 Market Capitalization: $193.71 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.51 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-4.60 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/30/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 53.75 EPS Growth vs. Year Ago Period: -720.45% vs. Previous Quarter: -216.67% Sales Growth vs. Year Ago Period: -90.17% vs. Previous Quarter: 0.00% ROE 12/31/25 - - 09/30/25 - -4,055.04 06/30/25 - -545.43 ROA 12/31/25 - - 09/30/25 - -88.90 06/30/25 - -64.40 Current Ratio 12/31/25 - - 09/30/25 - 13.15 06/30/25 - 16.41 Quick Ratio 12/31/25 - - 09/30/25 - 13.15 06/30/25 - 16.41 Operating Margin 12/31/25 - - 09/30/25 - -2,220.20 06/30/25 - -400.56 Net Margin 12/31/25 - - 09/30/25 - -2,909.10 06/30/25 - -274.42 Pre-Tax Margin 12/31/25 - - 09/30/25 - -2,411.38 06/30/25 - -132.29 Book Value 12/31/25 - - 09/30/25 - -2.74 06/30/25 - 5.50 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - 0.00

Powered by Zacks Investment Research ©